@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C01AA05> a ns1:ATCConcept ;
    skos:notation "C01AA05" ;
    skos:prefLabel "Digoxin"@cs,
        "Digoxin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0006386> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000375>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000687>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001430>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000002363>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003118>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003541> ;
    ns1:description "A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000133>,
        <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000238> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/DIGOXIN-0-125-LECIVA>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/DIGOXIN-0-250-LECIVA> ;
    ns1:hasPharmacokinetics <http://linked.opendata.cz/resource/ndfrt/pharmacokinetics/N0000000042> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003471>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008369>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009756>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009763>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009809> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C> ;
    ns1:mayPrevent <http://linked.opendata.cz/resource/ndfrt/disease/N0000001434> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000000507>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000508>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000683>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001434>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000002729>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000002895> ;
    ns1:title "Digoxin"@cs,
        "Digoxin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326> a ns1:PharmacologicalAction ;
    ns1:description "Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.     "@en ;
    ns1:title "Antiarytmika"@cs,
        "Anti-arrhythmia agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003471> a ns1:PharmacologicalAction ;
    ns1:description "Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).     "@en ;
    ns1:title "Kardiotonika"@cs,
        "Cardiotonic agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520> a ns1:PharmacologicalAction ;
    ns1:description "Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.     "@en ;
    ns1:title "Enzymy - inhibitory"@cs,
        "Enzyme inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000375> a ns1:DiseaseOrFinding ;
    ns1:description "A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.     "@en ;
    ns1:title "Amyloidóza"@cs,
        "Amyloidosis"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000507> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.     "@en ;
    ns1:title "Fibrilace síní"@cs,
        "Atrial fibrillation"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000508> a ns1:DiseaseOrFinding ;
    ns1:description "Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).     "@en ;
    ns1:title "Flutter síní"@cs,
        "Atrial flutter"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000683> a ns1:DiseaseOrFinding ;
    ns1:description "A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.     "@en ;
    ns1:title "Srdce - minutový objem nízký"@cs,
        "Cardiac output, low"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000687> a ns1:DiseaseOrFinding ;
    ns1:description "A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).     "@en ;
    ns1:title "Kardiomyopatie hypertrofická"@cs,
        "Cardiomyopathy, hypertrophic"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001430> a ns1:DiseaseOrFinding ;
    ns1:description "Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.     "@en ;
    ns1:title "Srdce - blokáda"@cs,
        "Heart block"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001434> a ns1:DiseaseOrFinding ;
    ns1:description "A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.     "@en ;
    ns1:title "Srdeční selhání"@cs,
        "Heart failure"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002363> a ns1:DiseaseOrFinding ;
    ns1:description "Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS.     "@en ;
    ns1:title "Konstriktivní perikarditida"@cs,
        "Pericarditis, constrictive"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002729> a ns1:DiseaseOrFinding ;
    ns1:description "Shock resulting from diminution of cardiac output in heart disease.     "@en ;
    ns1:title "Šok kardiogenní"@cs,
        "Shock, cardiogenic"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002895> a ns1:DiseaseOrFinding ;
    ns1:description "A generic expression for any tachycardia that originates above the BUNDLE OF HIS.     "@en ;
    ns1:title "Supraventrikulární tachykardie"@cs,
        "Tachycardia, supraventricular"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003118> a ns1:DiseaseOrFinding ;
    ns1:description "A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.     "@en ;
    ns1:title "Fibrilace komor"@cs,
        "Ventricular fibrillation"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003541> a ns1:DiseaseOrFinding ;
    ns1:description "An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).     "@en ;
    ns1:title "Komorová tachykardie"@cs,
        "Tachycardia, ventricular"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000133> a ns1:MechanismOfAction ;
    ns1:title "Enzyme Inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000238> a ns1:MechanismOfAction ;
    ns1:title "Na-K ATPases Interactions"@en .

<http://linked.opendata.cz/resource/ndfrt/pharmacokinetics/N0000000042> a ns1:Pharmacokinetics ;
    ns1:title "Renal Excretion"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008369> a ns1:PhysiologicEffect ;
    ns1:title "Conduction System Depolarization"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009756> a ns1:PhysiologicEffect ;
    ns1:title "Negative Chronotropy"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009763> a ns1:PhysiologicEffect ;
    ns1:title "Nodal Depolarization"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009809> a ns1:PhysiologicEffect ;
    ns1:title "Positive Inotropy"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/DIGOXIN-0-125-LECIVA> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C01AA05> ;
    ns1:title "DIGOXIN 0,125 LÉČIVA"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/DIGOXIN-0-250-LECIVA> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C01AA05> ;
    ns1:title "DIGOXIN 0,250 LÉČIVA"@cs .


